Analysis of genetic status of pivotal driver genes in pancreatic ductal adenocarcinoma and their correlation with clinicopathologic features

Analysis of genetic status of pivotal driver genes in pancreatic ductal adenocarcinoma and their correlation with clinicopathologic features

Objective: To investigate the relationship between genetic characteristics of pivotal driver genes and clinicopathological features in pancreatic ductal adenocarcinoma(PDAC). Methods: Mutations in related genes in 269 PDAC patients were detected with targeted sequencing, and the relationship between...

Full description

Bibliographic Details
Main Author:	XIE Wen, LIANG Huaiyu, DONG Lei, YUAN Fei, WANG Chaofu, GUO Yan
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2022-10-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|pancreatic ductal adenocarcinoma\|driver gene\|clinicopathological feature\|prognosis
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1674993665306-660271298.pdf

Similar Items

Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
by: Tsengelmaa Jamiyan, et al.
Published: (2020-06-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01)

Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
by: Debang Li, et al.
Published: (2018-10-01)

Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma
by: Carlo Caputo, et al.
Published: (2024-02-01)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018-01-01)

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2021-05-01)

Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries
by: Zheng Li, et al.
Published: (2023-01-01)

Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients
by: James M. Halle-Smith, et al.
Published: (2023-04-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
by: Chaobin He, et al.
Published: (2020-09-01)

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study
by: Weibo Li, et al.
Published: (2022-10-01)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017-05-01)

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
by: María Laura Gutiérrez, et al.
Published: (2021-09-01)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
by: Chaobin He, et al.
Published: (2019-11-01)

A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
by: Singh Puneet, et al.
Published: (2011-12-01)

A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma
by: Li-xiang Zhang, et al.
Published: (2020-04-01)

Identification of FEZ2 as a potential oncogene in pancreatic ductal adenocarcinoma
by: Chaozhi Yang, et al.
Published: (2022-01-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
by: Wen-Jing Liu, et al.
Published: (2018-01-01)

Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
by: Hong-Bin Li, et al.
Published: (2021-09-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
by: Natalia Michalak, et al.
Published: (2023-06-01)

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
by: Yufei Zhu, et al.
Published: (2022-10-01)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
by: Hao Lu, et al.
Published: (2022-09-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)

The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
by: Tian-Run Lv, et al.
Published: (2022-12-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
by: Jung-Soo Pyo, et al.
Published: (2021-11-01)

Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
by: Christina Jane Vellan, et al.
Published: (2022-02-01)

Molecular imaging of pancreatic ductal adenocarcinoma
by: Wei Huang, et al.
Published: (2023-10-01)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
by: Alessandro Coppola, et al.
Published: (2023-05-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Novel Treatment Strategies for Advanced Pancreatic Ductal Adenocarcinoma
by: CHENG Yuejuan, et al.
Published: (2022-03-01)